New Vision Medical Technology
Ophthalmic diagnostic hardware and intelligent diagnosis solutions provider.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
* | CNY20.0m Valuation: CNY500m | Series A | |
| Total Funding | 000k | ||
New Vision Medical Technology, operating as New Trials, is a Chinese company founded in 2020 that provides a comprehensive management and monitoring platform for clinical trials. The Software as a Service (SaaS) platform integrates a monitoring system, a clinical trial matching service, payment and financial systems, and an electronic filing system. This enables users, such as pharmaceutical companies and research organizations, to manage clinical trials more efficiently.
The company is headquartered in Hangzhou, China, and operates within the enterprise systems for healthcare industry. As a venture capital-backed entity, New Trials has successfully raised $14.1 million through several funding rounds, including an early-stage VC round in May 2021 and a Series A1 round in February 2025, with notable investors like Eight Roads.
Keywords: clinical trial management, clinical trial monitoring, SaaS, healthcare enterprise systems, electronic filing system, clinical trial matching, venture capital, Hangzhou, health-tech, clinical research solutions